Evogene (EVGN)
(Delayed Data from NSDQ)
$0.69 USD
+0.03 (4.72%)
Updated May 20, 2024 03:26 PM ET
After-Market: $0.66 -0.03 (-4.35%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Evogene Ltd. [EVGN]
Reports for Purchase
Showing records 1 - 20 ( 43 total )
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Big Week for Partnerships to Fund Development Pipelines
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
To Receive $3.5M Collaboration Agreement Payment
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Strong Quarter and Good Progress at Lavie Bio and Biomica
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B